Objective: To compare clinical outcomes between two first-generation endometrial ablation techniques. Design: Prospective comparative coorte. Setting: Tertiary public hospital, university teaching center. Seventy-three patients with abnormal uterine bleeding unresponsive to clinical treatment submitted to endometrial ablation from October 2011 to September 2013. Methods and Main Outcome Measures: Patients were assigned to either monopolar U-shaped electrode resection with rollerball electrocoagulation (group A, n = 36) or rollerball electrocoagulation alone (group B, n = 37). Mean follow-up length was 359 (280 -751) and 370 days (305 -766) in groups A and B, respectively. Bleeding pattern, associated symptoms, failure/success rates were assessed 30, 90, 180 and 360 days post-procedure. Findings: Patient characteristics were similar in both groups (P ≥ 0.05). Surgery duration (mean of 48.5 [±12.0] vs. 31.9 [±5.6] min, P < 0.001) and medium distention use (5.700 mL vs. 3.500 mL, P < 0.01) were decreased in group B. Post-ablation clinical improvement was considerable in both groups. Vaginal discharge incidence after the procedure was lower in group B (30.5% vs. 8.1%, P < 0.05). Hysterectomy rate was 9.6%. Overall success rate was 86.1% and 88.1% in groups A and B, respectively. Conclusions: Endometrial ablation using rollerball electrocoagulation alone may be considered safer than resection with rollerball electrocoagulation, which requires shorter surgical time and less distention medium, and is associated with lower postoperative vaginal discharge incidence. Success rate did not # Adjunct Professor III and Principal Investigator.
Introduction
Abnormal uterine bleeding (AUB) is defined as any deviation from the normal menstrual cycle pattern including changes in the frequency, duration or volume of blood flow [1] [2] . Excessive menstrual blood loss, which can be accompanied by other symptoms, very often interferes with a woman's physical and mental well-being bringing limitations to daily life activities and changes in social behavior that might reduce health-related quality of life-HRQOL [3] [4] [5] .
AUB affects one woman in five, and most commonly occurs around menarche and menopause [3] [5] [6] . In the general population, AUB prevalence is estimated at 11% -13% and increases with age, reaching 24% in women aged 36 -40 years [6] [7] . The management for AUB has been widely investigated over the past years with the goals of stopping bleeding or promoting regular menstrual cycles with adequate flow volume, taking into account the patient's desire for future fertility [1] . Initial medical therapy includes the use of non-steroidal antiinflammatory drugs (NSAIDs), antifibrinolytic drugs, combination oral contraceptives (COC) or oral progestins, levonorgestrel intrauterine system (LNG-IUS), and hormone replacement therapy during climacterium [6] [8] . However, when medications are not effective, surgical treatment might be indicated.
In the past, the first option was curettage, which has a reasonable diagnostic performance, but is of little therapeutic value. The final and definitive treatment is hysterectomy, especially in women without reproductive desire. Over the last two decades, diagnostic tools have significantly advanced and new therapy modalities have been developed. These new procedures are less invasive and offer the possibility of preserving the uterus and avoiding the morbidity related to hysterectomy, which varies between 5.2% to 9.4%, reaching up to 40% in some series [9] [10] [11] . One of the alternatives to hysterectomy is endometrial ablation, which destroys the endometrium using different sources of energy [12] .
The first-generation endometrial ablation techniques include endometrial resection, rollerball electrocoagulation, and Nd:YAG laser ablation [13] . Secondgeneration procedures are less invasive and easy to perform, but are performed without direct hysteroscopic visualization [14] . They include the use of thermal energy, cryosurgery and microwave energy. Patient satisfaction rate after endometrial ablation ranges from about 87% to 93% [15] . According to follow-up studies, satisfaction rate after endometrial ablation is 86.4% and 80.6% at 2.5 and 5 years, respectively [15] [16] . Moreover, endometrial ablation has been demon-
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strated to improve quality of life even among obese women (BMI > 30 kg/m   2   ) and those with coagulopathies [17] - [22] . Nonetheless, between 9.3% and 13.6% of the patients undergoing endometrial ablation may need retreatment consisting from medical therapy or repeat endometrial ablation to hysterectomy, at intervals ranging from 1 to 8 years [23] [24] [25] [26] .
Although a large number of studies have compared first-generation with second-generation ablation techniques, comparisons between the first-generation procedures endometrial resection and electrocoagulation using rollerball alone were performed by a limited number of studies [13] [27] [28] [29] [30] . The type of electrical current used in the procedure may interfere with surgical outcome as the currents used in endometrial resection and rollerball coagulation differ in maximum peak tension and modulation [31] . Thus, this study consisted of a prospective comparative analysis between clinical outcomes of two different first-generation techniques in AUB patients unresponsive to medical therapy.
Material and Methods
This prospective analytic study included AUB patients who underwent endome- Eligibility criteria for endometrial ablation were as follows: abnormal uterine bleeding unresponsive to medical treatment for at least 12 months, absence of pregnancy desire; normal oncologic colpocytology; no genital infection on physical examination, having undergone transvaginal ultrasonographic examination and office hysteroscopy with endometrial biopsy to rule out malignant processes and hysterometric measurement ≤ 12 cm. The presence of benign conditions such as endometrial polyps and submucosal fibroids < 2 cm did not contraindicated the inclusion in the study [7] . Patients with cardiovascular problems as well as those who refused to participate were excluded. During the study period 80 women adequately fulfilled the eligibility criteria and were selected for screening. After proper counseling about the purposes of research and interventions to be performed, only 73 women agreed to participate and were included in the evaluation.
The procedure was performed under spinal anesthesia and no endometrial preparation prior to surgery was carried out. Antisepsis was performed using 10% povidone-iodine in aqueous solution. Cervical dilatation to Hegar number 9 was performed for the easy passage of the resectoscope with no leaking of the distention medium through the cervix. Depending on availability, either 3% sorbitol or 5% mannitol was used as distention medium. Prophylactic antibiotic therapy with cefazolin 2 grams I.V. was administered 30 minutes before surgery according to our operative room routine.
With the patient already in the operating room a sealed envelope containing The rollerball electrode was used to coagulate around the tubal ostia and margin of the inner cervical os, determined as the inferior resection limit. The electrode was then switched to the U-shaped loop, set at the same current as in group A. The laterals were removed from the tubal ostia to the isthmus, and the posterior and anterior walls were resected. Hemostasis was attained moving a rollerball electrode set at coagulation current over the entire uterine cavity and bleeding sites. In group B, a rollerball electrode was used to cauterize the laterals, from the tubal ostia to the isthmus, and the posterior and anterior walls. Intrauterine lesions such as polyps and submucosal fibroids found in group B patients were previously removed using the U-shaped loop electrode with a cutting current of 100 W, blend 1. Patients stayed in hospital for 12 -24 hours after surgery for observation of bleeding and recovery from anesthesia, and were instructed to resume normal daily activities after 3 days. Based on each patient's menstrual calendar, menstrual pattern was assessed over a mean period of 12 months (30, 90, 180, and 360 days) after the surgical procedure. 
Results
During the study period, 73 endometrial ablations were performed. Participants were submitted to endometrial resection + rollerball coagulation (group A, n = 36) or rollerball electrocoagulation alone (group B, n = 37). Mean follow-up length was 359 days (280 -751) in group A and 370 days (305 -766) in group B.
Clinical/epidemiological characteristics were similar between groups, except for a higher mean number of children in group B (Table 1) .
No significant differences between groups were observed regarding ultrasonographic variables and hysterometric measures routinely taken after diagnostic hysteroscopy ( Table 2 ). The incidence of hysteroscopic findings was similar in both groups (P ≥ 0.05). To estimate the likelihood of successful hysteroscopic fibroid removal, the classification system described by Lasmar et al. was used, taking into account fibroid size, topography, extension of the base in relation to the uterine wall, penetration into the myometrium, and location on lateral walls (STEPW) [36] . Lasmar score ranged from 2 to 6 in group A, and from zero to 6 in group B (Table 2) . (Table 3) . At the time of surgery, endometrial pattern was similar in both groups, with 27.8% of the patients in group A, and 35.1% of those in group B having undergone preoperative uterine curettage due to exuberant secretory endometrium.
Histopathological examination revealed statistical similarities between groups (Table 3) . Whereas 5 patients from group A (13.9%) had endometrial hyperplasia without atypia, 3 patients in group B (8.1%), also diagnosed with endometrial polyp, showed endometrial hyperplasia with atypia present in one case (2.7%) (P ≥ 0.05). This patient later underwent hysterectomy, which confirmed the presence of a lesion restricted to the endometrium. Adenomyosis, associated with endometrial polyp, was found in only 3 patients (8.1%) from group B. There were no cases of surgical site infection and the incidence of vaginal discharge after procedure was lower in group B (30.5% vs. 8.1%, P < 0.05) ( Table 3 ). (Table 4) . By the end of follow-up, no differences were observed between groups regarding the menstrual pattern achieved, such as absence of menstruation (40% vs. 51.5%), reduced bleeding or infrequent menstruation (42.9 vs. 39.4%), and normal menstrual cycle (8.6% vs. 9.1%) (P ≥ 0.05). .6) 8 (29.6) 11 (37.9) 14 (40) 15 ( Seven patients (9.6%) underwent hysterectomy, 3 in group A, and 4 in group B. Of the 4 group B patients, 2 (5.4%) underwent hysterectomy at the time of ablation due to technical difficulties and intraoperative bleeding. The other 2 patients from group B, and the 3 patients from group A underwent hysterectomy during the follow-up period, at least 181 days after the procedure, due to persistent AUB, post-ablation incapacitating dysmenorrhea and/or pelvic pain. In only 1 case from group B, endometrial re-ablation was performed after 144 days due to persistent AUB (Table 4) .
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Hemoglobin levels significantly improved in both groups, increasing from 
Discussion
Endometrial ablation was first performed by Goldrath and colleagues in 1981.
However Endometrial ablation success rate has been reported to be around 80% -90% [7] [39]. Shavell et al. found that, through five years of follow-up, hysterectomy was performed subsequently to endometrial ablation in 13.4% of the cases, primarily due to persistent bleeding and pelvic pain [24] . Longinotti et al., in 8-year follow-up of 754 women, reported a 26% probability of hysterectomy subsequent to endometrial ablation, with pelvic pain being the main reason for the procedure in 22% of the cases [25] . According to the literature, reduced bleeding or infrequent menstruation is achieved in 48% -60%, absence of menstruation in During postoperative follow-up, 5 patients (3 from group A and 2 from group B) underwent hysterectomy, and 1 patient from group B had an endometrial reablation. The reasons for hysterectomy were persistent AUB and incapacitating dysmenorrhea in the 3 patients from group A, and persistent severe pelvic pain in both patients from group B. Endometrial reablation was performed in one group B patient due to persistent heavy menstrual bleeding [7] . The procedure was followed by improved clinical condition and patient satisfaction.
Five patients from group A and 2 patients from group B underwent endometrial ablation combined with polypectomy [7] . Histopathological examination showed simple hyperplasia with no atypia in the polyp. Therefore, they were clinically treated with medroxyprogesterone for an initial period of 6 months, and are still being followed up [42] . In the only case where histopathological examination revealed atypical complex hyperplasia, hysterectomy was performed and the patient's condition has evolved satisfactorily since then.
The patient with a history of pulmonary thromboembolism (group B) had to stay in hospital for longer. Despite adequate preoperative preparation, she had acute deep vein thrombosis of a lower limb. However, her condition evolved extremely well and she was discharged 13 days later with absent menstruation and still on warfarin. Consistently with the literature, the only case of water intoxication was seen in an obese patient undergoing endometrial ablation and myomectomy using 3% sorbitol as distention medium [7] [43]. This group A patient showed a BMI of 35 kg/m 2 and a immediate postoperative sodium plasma level of 116 mEq/L. Clinical support measures were taken, and the patient was discharged in good condition 4 days later.
Vaginal discharge is described as a normal clinical complaint within the first 30 days after endometrial ablation, provided that fever and fetid odor are absent.
In this study, the incidence of vaginal discharge during the early postoperative period was higher in group A than in group B. However, good resolution was observed in all cases after clinical treatment with oral imidazole derivatives.
A major limitation of our study is not evaluating objectively menstrual bleeding before and after the procedure. As most patients referred to perform endometrial ablation held initial follow-up at primary care services of our region, the application of pictorial blood loss assessment chart (PBLAC) was not standardized preoperatively, hindering the use of this valuable tool in estimating bleeding. Alternatively, collection of used sanitary product with subsequent extraction of alkaline hematin should be considered. However, this method is much more complex, costly and not available in our service. Although being a semi-subjective assessment by counting the number of sanitary pads the reduction observed in the number of pads used in the day of heaviest flow and throughout the menstrual period associated with the increase in hemoglobin levels after the procedure confirms clinical improvement with both techniques used. Another issue to
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highlight is the fact that our institution is a university center where novice doctors are instructed in minimally invasive techniques which can explain some of the observed complications and also the amount of distension medium used to complete the procedures.
Conclusion
Endometrial ablation using rollerball electrocoagulation alone, which is easier to perform, may be considered safer. Besides taking shorter time in surgery and requiring a smaller amount of distention medium, it is associated with a lower postoperative vaginal discharge incidence. 
